A detailed history of Manufacturers Life Insurance Company, The transactions in Insmed Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 288,073 shares of INSM stock, worth $20.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
288,073
Previous 283,011 1.79%
Holding current value
$20.3 Million
Previous $19 Million 10.91%
% of portfolio
0.02%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$62.0 - $79.01 $313,844 - $399,948
5,062 Added 1.79%
288,073 $21 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $1.11 Million - $3.51 Million
50,330 Added 21.63%
283,011 $19 Million
Q1 2024

May 14, 2024

BUY
$25.72 - $29.94 $531,015 - $618,141
20,646 Added 9.74%
232,681 $6.31 Million
Q4 2023

Feb 13, 2024

BUY
$23.42 - $31.74 $68,644 - $93,029
2,931 Added 1.4%
212,035 $6.57 Million
Q3 2023

Nov 15, 2023

BUY
$19.86 - $26.93 $209,483 - $284,057
10,548 Added 5.31%
209,104 $5.28 Million
Q2 2023

Aug 11, 2023

SELL
$16.44 - $21.1 $100,333 - $128,773
-6,103 Reduced 2.98%
198,556 $4.19 Million
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $3,349 - $4,476
206 Added 0.1%
204,865 $3.49 Million
Q4 2022

Aug 11, 2023

BUY
$16.98 - $23.15 $317,746 - $433,205
18,713 Added 10.06%
204,659 $4.09 Million
Q4 2022

Feb 13, 2023

BUY
$16.98 - $23.15 $317,746 - $433,205
18,713 Added 10.06%
204,659 $4.09 Million
Q3 2022

Aug 11, 2023

BUY
$20.88 - $28.21 $171,132 - $231,209
8,196 Added 4.61%
185,946 $4.01 Million
Q3 2022

Nov 03, 2022

BUY
$20.88 - $28.21 $171,132 - $231,209
8,196 Added 4.61%
185,946 $4.05 Million
Q2 2022

Aug 11, 2023

BUY
$17.07 - $25.71 $106,329 - $160,147
6,229 Added 3.63%
177,750 $3.51 Million
Q2 2022

Aug 15, 2022

BUY
$17.07 - $25.71 $106,329 - $160,147
6,229 Added 3.63%
177,750 $3.55 Million
Q1 2022

Aug 11, 2023

SELL
$20.42 - $28.13 $680,884 - $937,966
-33,344 Reduced 16.28%
171,521 $4.03 Million
Q1 2022

May 20, 2022

BUY
$20.42 - $28.13 $2.3 Million - $3.16 Million
112,407 Added 190.15%
171,521 $3.96 Million
Q4 2021

Feb 16, 2022

BUY
$25.89 - $33.45 $1,967 - $2,542
76 Added 0.13%
59,114 $1.61 Million
Q3 2021

Nov 12, 2021

BUY
$22.46 - $29.47 $22,774 - $29,882
1,014 Added 1.75%
59,038 $1.63 Million
Q2 2021

Aug 12, 2021

BUY
$24.17 - $36.01 $28,786 - $42,887
1,191 Added 2.1%
58,024 $1.65 Million
Q1 2021

May 03, 2021

SELL
$32.28 - $44.3 $113,819 - $156,201
-3,526 Reduced 5.84%
56,833 $1.94 Million
Q4 2020

Feb 12, 2021

BUY
$31.45 - $40.54 $67,774 - $87,363
2,155 Added 3.7%
60,359 $2.01 Million
Q3 2020

Nov 09, 2020

SELL
$26.0 - $34.5 $46,202 - $61,306
-1,777 Reduced 2.96%
58,204 $1.87 Million
Q2 2020

Aug 10, 2020

BUY
$14.11 - $29.42 $47,903 - $99,880
3,395 Added 6.0%
59,981 $1.61 Million
Q1 2020

May 15, 2020

BUY
$13.63 - $33.98 $42,389 - $105,677
3,110 Added 5.82%
56,586 $907,000
Q4 2019

Feb 14, 2020

SELL
$16.12 - $24.98 $12,347 - $19,134
-766 Reduced 1.41%
53,476 $1.28 Million
Q3 2019

Nov 12, 2019

BUY
$15.49 - $25.78 $90,229 - $150,168
5,825 Added 12.03%
54,242 $991,000
Q2 2019

Aug 14, 2019

SELL
$23.0 - $32.19 $41,262 - $57,748
-1,794 Reduced 3.57%
48,417 $1.24 Million
Q1 2019

May 13, 2019

BUY
$13.91 - $31.15 $46,236 - $103,542
3,324 Added 7.09%
50,211 $1.46 Million
Q4 2018

Feb 14, 2019

SELL
$11.6 - $18.7 $37,270 - $60,083
-3,213 Reduced 6.41%
46,887 $615,000
Q3 2018

Nov 14, 2018

SELL
$18.95 - $28.08 $131,380 - $194,678
-6,933 Reduced 12.16%
50,100 $1.01 Million
Q2 2018

Aug 14, 2018

BUY
$20.0 - $29.72 $3,140 - $4,666
157 Added 0.28%
57,033 $1.35 Million
Q1 2018

May 15, 2018

SELL
$21.69 - $32.99 $26,288 - $39,983
-1,212 Reduced 2.09%
56,876 $1.28 Million
Q4 2017

Feb 08, 2018

BUY
$26.43 - $31.78 $49,979 - $60,095
1,891 Added 3.36%
58,088 $1.81 Million
Q3 2017

Nov 14, 2017

BUY
$11.61 - $31.21 $652,447 - $1.75 Million
56,197
56,197 $1.76 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.56B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.